Table 5.
NORGEP [14] | Laroche [13] | Rancourt [17] | Beers [4] | STOPP [16] | Winit-Watjana [15] | |
---|---|---|---|---|---|---|
Number of medications considered as PIMs | n = 96 (5.6) | n = 132 (7.7) | n = 185 (10.8) | n = 177 (10.3) | n = 199 (11.6) | n = 254 (14.8) |
Reported as DRP (%) | 40 (41.7) | 51 (38.6) | 73 (39.5) | 69 (39) | 61 (30.7) | 86 (33.9) |
DRP follow up in 24 weeks (%) | 29 (72.5) | 36 (70.6) | 45 (61.6) | 43 (62.3) | 36 (59) | 59 (68.6) |
Problem-solving rate* (%) | 22 (75.9) | 26 (72.2) | 38 (84.4) | 31 (72.1) | 30 (83.3) | 46 (78) |
(Problem totally solved + problem partly solved/follow-up numbers). The ranking of each set of criteria was based on their prevalence in our study population, from low to high. Abbreviations: NORGEP, Norwegian General Practice criteria; STOPP, the Screening Tool of Older Person's Prescriptions.